NO20062316L - Nye CXCL8 antagonister - Google Patents

Nye CXCL8 antagonister

Info

Publication number
NO20062316L
NO20062316L NO20062316A NO20062316A NO20062316L NO 20062316 L NO20062316 L NO 20062316L NO 20062316 A NO20062316 A NO 20062316A NO 20062316 A NO20062316 A NO 20062316A NO 20062316 L NO20062316 L NO 20062316L
Authority
NO
Norway
Prior art keywords
cxcl8
new
antagonists
cxcl8 antagonists
cxcl
Prior art date
Application number
NO20062316A
Other languages
English (en)
Norwegian (no)
Inventor
Amanda Proudfoot
Jeffrey Shaw
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Research Systems filed Critical Applied Research Systems
Publication of NO20062316L publication Critical patent/NO20062316L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/54Interleukins [IL]
    • C07K14/5421IL-8
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO20062316A 2003-10-22 2006-05-22 Nye CXCL8 antagonister NO20062316L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03103909 2003-10-22
PCT/EP2004/052637 WO2005040210A2 (en) 2003-10-22 2004-10-22 Novel cxcl8 antagonists

Publications (1)

Publication Number Publication Date
NO20062316L true NO20062316L (no) 2006-06-23

Family

ID=34486342

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20062316A NO20062316L (no) 2003-10-22 2006-05-22 Nye CXCL8 antagonister

Country Status (10)

Country Link
US (1) US20090022657A1 (de)
EP (1) EP1673388B1 (de)
JP (1) JP2007533300A (de)
AT (1) ATE415420T1 (de)
AU (1) AU2004283910A1 (de)
CA (1) CA2534828A1 (de)
DE (1) DE602004018014D1 (de)
IL (1) IL175019A0 (de)
NO (1) NO20062316L (de)
WO (1) WO2005040210A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3089489C (en) * 2018-01-18 2025-02-04 Third Wave Bioactives, Llc FRUIT AND VEGETABLE-BASED FERMENTED PRODUCT COMPOSITIONS, AND METHODS FOR PREPARING AND USING THESE
TR201811689A2 (tr) * 2018-08-10 2018-09-21 Hacettepe Ueniversitesi Cxcl8 ami̇no ucu öncül di̇zi̇si̇nden türevlenen i̇mmünmodülatör pepti̇t

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3078892A (en) * 1991-12-04 1993-06-28 Biomedical Research Centre Limited, The Human interleukin-8 analogs
AU3681795A (en) * 1994-09-23 1996-04-09 University Of Nebraska Board Of Regents Polypeptide agonists and antagonists of human interleukin-8
UA77950C2 (en) * 2000-10-04 2007-02-15 Applied Research Systems Use of mutants of cc chemokines for treatment of multiple sclerosis

Also Published As

Publication number Publication date
EP1673388B1 (de) 2008-11-26
WO2005040210A2 (en) 2005-05-06
DE602004018014D1 (de) 2009-01-08
JP2007533300A (ja) 2007-11-22
AU2004283910A1 (en) 2005-05-06
CA2534828A1 (en) 2005-05-06
ATE415420T1 (de) 2008-12-15
IL175019A0 (en) 2006-08-20
EP1673388A2 (de) 2006-06-28
US20090022657A1 (en) 2009-01-22
WO2005040210A3 (en) 2005-06-23

Similar Documents

Publication Publication Date Title
ATE548363T1 (de) 3,5-disubstituierte pyrid-2-one, die sich als inhibitoren der tec-familie von nicht-rezeptor- tyrosinkinasen eignen
ATE451376T1 (de) Zusammensetzungen, die sich als inhibitoren von proteinkinasen eignen
ATE446313T1 (de) Muteine von tränen-lipocalin
DE602004014117D1 (de) Thiazole zur verwendung als inhibitoren von protein-kinasen
DE60327999D1 (de) Azolylaminoazine als inhibitoren von proteinkinasen
EP1796669A4 (de) Aminopiperidine als dipeptidylpeptidase-iv-inhibitoren zur behandlung oder prävention von diabetes
ATE482213T1 (de) Als inhibitoren von proteinkinasen geeignete pyrazoloä1,5-aüpyrimidine
ATE466580T1 (de) Azolylaminoazine als proteinkinasehemmer
ATE468336T1 (de) Azolylaminoazine als proteinkinasehemmer
ATE365733T1 (de) Zusammensetzungen brauchbar als protein-kinase- inhibitoren
NO20084652L (no) Deazapuriner anvendelige som inhibitorer av januskinaser
NO20082476L (no) Bicykliske forbindelser med kinaseinhiberende aktivitet
DE602006004844D1 (de) Pyrrolopyrimidine verwendbar als protein kinase inhibitoren
ATE528302T1 (de) 3,5-disubstituierte pyrid-2-one, die als hemmer der tec-familie von nicht-rezeptor tyrosin- kinasen nützlich sind
MXPA06011327A (es) Azaindoles utiles como inhibidores de jak y otras proteinas cinasas.
EP1673078A4 (de) Benzylether- und benzylamino-beta-sekretase-hemmer zur behandlung von alzheimer-krankheit
EA200501710A1 (ru) Замещённые карбоновые кислоты
EP1888066A4 (de) Aminocyclohexane als dipeptidylpeptidase-iv-hemmer zur behandlung bzw. prävention von diabetes
NO20052595L (no) Sammensetninger anvendelige som inhibitorer av ROCK- og andre proteinkinaser.
ATE450530T1 (de) Zusammensetzungen zur verwendung als protein- kinase-inhibitoren
EP1921917A4 (de) Kondensierte aminopiperidine als dipeptidylpeptidase-iv-inhibitoren zur behandlung oder prävention von diabetes
EA200602243A1 (ru) 3-аминоциклопентанкарбоксамиды в качестве модуляторов хемокиновых рецепторов
ATE389651T1 (de) Als inhibitoren von c-met geeignete pyrrolzusammensetzungen
MXPA05009014A (es) Antagonistas del receptor ccr-3.
DE602006017574D1 (de) Als protein-kinase-inhibitoren nutzbare benzimidazole

Legal Events

Date Code Title Description
CREP Change of representative

Representative=s name: ONSAGERS AS, POSTBOKS 6963 ST OLAVS PLASS, 0130 OS

FC2A Withdrawal, rejection or dismissal of laid open patent application